ArticleThe Analyst2009

A microfluidic technique for monitoring bloodstream analytes indicative of C-peptide resistance in type 2 diabetes.

Teresa D'Amico Oblak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.